Magnolin inhibits prostate cancer cell growth in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Magnolin inhibits prostate cancer cell growth in vitro and in vivo

Published:2017-03 Issue: Volume:87 Page:714-720
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Huang Yeqing,Zou Xiangyu,Zhang Xiaowen,Wang Feng,Zhu Weidong,Zhang Guangyuan,Xiao Jun,Chen Ming

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference21 articles.

1. Percutaneous penetration of anticancer agents: past, present and future;Ita;Biomed. Pharmacother.,2016

2. A comparative study of prostate cancer detection and management in China and in France;Peyromaure;Can. J. Urol.,2009

3. Active surveillance for prostate cancer: for whom?;Klotz;J. Clin. Oncol,2005

4. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer;Walz;J. Clin. Oncol.,2007

5. Cancer statistics;Siegel;CA Cancer J. Clin.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnolin alleviated DSS‐induced colitis by inhibiting ALOX5‐mediated ferroptosis;The Kaohsiung Journal of Medical Sciences;2024-02-10

2. Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation;Cancer Letters;2024-02

3. Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways;Acta Dermato-Venereologica;2023-11-13

4. Antiandrogenic activity and bioavailability of magnolol analogs – A potential for prostate cancer therapeutics;Phytomedicine Plus;2023-11

5. Magnolin Inhibits Paclitaxel-Induced Cold Allodynia and ERK1/2 Activation in Mice;Plants;2023-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3